Andrew E Place

19PUBLICATIONS
113CO-AUTHORS
AllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 11, 2026
Pegaspargase Rechallenge Following Grade 2 Hypersensitivity Reaction in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 16-001.

|Jul 17, 2026
Allogeneic HSCT outcomes and impact of defibrotide prophylaxis on SOS after inotuzumab in pediatric B-ALL.

|May 26, 2026
A First-in-Pediatric Study of ALRN-6924, a Novel Stapled-Peptide Dual MDM2/MDMX Inhibitor, for Children with Advanced Hematologic and Solid Malignancies.

|Mar 13, 2026
Venetoclax in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results of a Phase 1 Study.

Daniel A Morgenstern, Giuseppe Barone, Nadege Corradini

|Apr 23, 2025
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia.

Seth E Karol, Seong L Khaw, C Michel Zwaan

|Mar 10, 2025
Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.

Andrew E Place, Seth E Karol, Christopher J Forlenza

Pageof 4

Frequent Collaborators

4 joint publications

Marlise R Luskin

4 joint publications

Giacomo Gotti

4 joint publications

Todd M Cooper

3 joint publications

Maria-Luisa Sulis